- MarketWatch•6 days ago
Health-care shares tumbled Wednesday, making it the worst performing of the S&P 500 Index's ten sectors, as pricing issues in the industry flared up again, first inflamed by an astronomical price hike ...
- The Wall Street Journal•7 days ago
Pfizer’s $14 billion deal to buy Medivation and its prostate-cancer drug Xtandi is the latest in a long line of big pharmaceutical company acquisitions of smaller companies with prized assets. Here is ...
Merck & Co., Inc. (MRK)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||62.94 x 500|
|Ask||63.10 x 100|
|Day's Range||62.78 - 63.02|
|52wk Range||47.97 - 64.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||34.47|
|Avg Vol (3m)||9,883,720|
|Dividend & Yield||1.84 (2.93%)|